|
22033-26033
|
|
Phase III low grade gliomas with stratification for genetic 1p/19q loss.
(B.Baumert, R.Stupp) |
|
design
|
|
|
|
|
|
|
|
22042-26042 |
|
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a phase II trial (D. Weber)
|
|
design |
| |
|
|
|
|
|
26053-22054 |
|
CATNON: anaplastic glioma without 1p19q loss (EORTC/NCI-C/RTOG/Cancer UK/HUB/NOA intergroup) (M. Van den Bent, B. Baumert)
|
|
design |
| |
|
|
|
|
|
22061-26062 |
|
Randomized phase III newly diagnosed glioblastoma multiforme in elderly patients
(A. Brandes, J. Menten)
|
|
design |
| |
|
|
|
|
| 26082-22081 |
|
Temsirolimus (CCI-779) with concomitant radiation therapy, followed by temsirolimus maintenance therapy versus radiochemotherapy with concomitant and adjuvant temozolomide in subjects with newly diagnosed GBM without methylation of the MGMT gene promoter – a randomized multicentre open-label phase II study
(W.Wick, G. Pesce) |
|
design |
| |
|
|
|
|
|
|
|
|
|
|
